8 arm PEG derivatives have multiple reactive groups that can be used to modify proteins, peptides and other materials via their functional groups. PEGylation can increase solubility and stability and reduce immunogenicity of peptides and proteins. It can also suppress the non-specific binding of charged molecules to the modified surfaces. .
Especificações
Especificações e pureza
MW 20000 Da
Condições de armazenamento de armazenamento
Room temperature
Enviado em
Normal
Dados avançados
Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Find and download the COA for your product by matching the lot number on the packaging.
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Revisões
Avaliações dos Clientes
Application Protocols
Manufacturer-validated application protocols, tested methods, and recommended dilutions are not specified for this item. Please refer to the literature and adapt to your system.
General high-level workflow considerations (non-validated, literature guidance):
Surface capture: Prepare streptavidin-coated surface; block; incubate with 8 Arm PEG Biotin in appropriate buffer; wash to remove unbound polymer; proceed with binding of complementary biotinylated entities as needed.
Hydrogel formation: Combine calculated equivalents of biotin end groups with streptavidin under gentle mixing at near-neutral pH; assess gelation and adjust ratios.
Nanoconjugation: Disperse nanoparticles compatible with aqueous buffers; introduce streptavidin or biotinylated partners in controlled order to avoid uncontrolled aggregation; purify by centrifugation/SEC.
For robust outcomes, determine the end-group concentration from the CoA (Mn and DOF) before setting stoichiometry. If these data are unavailable for this SKU, contact Technical Support for the lot-specific CoA.
Biological Roles
This product is for research use only. The following describes known biological roles of its components (general/literature), not properties validated for this item.
Biotin (vitamin B7/H) (general):
A cofactor for carboxylase enzymes in metabolism (e.g., acetyl-CoA carboxylase). As a pendant group on PEG, its primary laboratory utility is the exceptionally tight, specific binding to avidin/streptavidin/NeutrAvidin.
PEG (polyethylene glycol) (general):
Hydrophilic, protein-resistant polymer that reduces nonspecific adsorption and aggregation; often used to impart “stealth” and spacing in biomaterials.
Multivalency effects (general):
8-arm presentation increases local avidity and can enhance capture efficiency on streptavidin-functionalized surfaces relative to mono-PEG-biotin, while also enabling network formation if multiple binding sites are engaged simultaneously.
Interactions:
Biotin–streptavidin binding is noncovalent but extremely tight (Kd in femtomolar range, literature) and is relatively tolerant to pH 4–10 and moderate detergents/salts; dissociation typically requires harsh conditions (e.g., boiling SDS or 6–8 M guanidine, literature).
Item-specific biological testing, endotoxin levels, and binding capacity: Not specified for this item; refer to CoA/Spec Sheet.
Buffer Applications
This product is not itself a buffer component. However, successful use of 8 Arm PEG Biotin commonly relies on appropriate buffers for streptavidin-based workflows (general guidance).
Recommended buffer types (general/literature):
PBS, TBS, or HEPES at near-neutral pH (≈7.2–7.6) to maintain protein activity and PEG stability.
Include moderate ionic strength (e.g., ~150 mM NaCl, literature) to reduce nonspecific interactions.
Additives (general):
Low levels of Tween-20 (0.01–0.05%) can reduce nonspecific binding on surfaces; validate compatibility with your assay.
Avoid free biotin and biotin-containing supplements (e.g., serum with high biotin) which can compete for binding.
Sterilization (general): Filter sterilize solutions (0.22 µm) when needed for cell-adjacent workflows; avoid heat sterilization that could denature partner proteins.
Item-specific buffer compatibility ranges, pH stability windows, and precipitation behavior: Not specified for this item; refer to CoA/Spec Sheet.
Green Alternatives
Sustainability considerations for 8 Arm PEG Biotin focus on solvent and process choices rather than substitution of the macromolecule itself (general guidance).
Prefer aqueous media whenever possible to minimize VOC use and improve safety for protein-facing workflows.
Avoid chlorinated solvents; if an organic co-solvent is needed for dissolution, favor DMSO or ethanol over DMF/DMAC (balance performance with downstream protein compatibility).
Minimize waste in affinity workflows by regenerating streptavidin surfaces when feasible (e.g., using gentle denaturation protocols, literature), acknowledging potential loss of activity over cycles.
Comparison (general, not item-specific):
8-arm PEG-biotin vs mono-/di-PEG-biotin:
Resource efficiency: higher valency can reduce total reagent mass to achieve a target biotin density.
Tradeoff: higher molecular weight may increase viscosity and slow diffusion; potential for network formation leading to fouling if overdosed.
PEG-biotin vs small-molecule biotinylation reagents:
PEG scaffold provides hydrophilicity and spacing, reducing nonspecific binding.
Tradeoff: polymer manufacturing footprint can be higher; ensure suppliers with responsible sourcing and provide CoA with PDI control.
Item-specific green certifications, residual solvent specs, and manufacturing details: Not specified for this item; refer to CoA/Spec Sheet.
Pharmaceutical Uses
No clinical or therapeutic claims are made for this product. In formulation and manufacturing research contexts (general/literature):
PEG is widely used as an excipient (solubilizer, viscosity modifier, stabilizer) in drug products; star PEGs can modulate rheology and surface properties of coatings and delivery vehicles.
Biotinylated PEGs serve as affinity handles for assembling or assaying biotin–(strept)avidin interactions during process development, analytical testing, or device functionalization.
Applications may include research on biosensor surface preparation, affinity purification platforms, or diagnostic prototype assemblies where high-density biotin presentation is desired.
Item-specific pharmacopeial status (USP/EP), GMP status, endotoxin/bioburden limits, and residual solvent specs: Not specified for this item; refer to CoA/Spec Sheet. Use is restricted to research use only as stated for SKU A163132.
Physical Properties
Item-specific physical constants are not provided for this product. Typical behavior for 8-arm PEG-biotin is summarized for context; values are literature/general and not product specifications.
State/appearance (item-specific): Not specified for this item; refer to CoA/Spec Sheet. Star PEG-biotins are commonly supplied as white to off-white solids or as dry powders (general).
Solubility (general/literature):
High water solubility expected due to PEG; terminal biotin groups may modestly reduce solubility versus nonfunctional PEG, especially at very high degrees of substitution or in high-salt buffers.
Typically soluble in water, PBS, Tris, HEPES, and polar organics like DMSO (general). Exact solubility limit for this item: Not specified.
Density, refractive index, logP, pKa: Not specified for this item. PEG segments are non-ionic, biotin is neutral near physiological pH (general).
Thermal properties: Melting/softening behavior and Tg for PEGs depend on arm length and polydispersity (general; Tg for linear PEGs often below 0 °C, literature). Item-specific BP/MP/Tg: Not specified for this item; refer to CoA/Spec Sheet.
Hygroscopicity (general): PEGs can be mildly hygroscopic; drying under vacuum can help prepare anhydrous material. Item-specific water content: Not specified.
Viscosity (general): Aqueous solutions may be moderately viscous at high concentrations; viscosity scales with arm length and concentration. Item-specific data: Not specified.
Quality and Grades
Grade/purity (item-specific): Not specified for this item; refer to CoA/Spec Sheet. For macromolecules, “purity” typically encompasses organic purity, removal of residual biotin/linker, and absence of low-MW species (general).
Key quality attributes for 8-arm PEG-biotin (general, what to expect on a CoA):
Number-average molecular weight (Mn) and weight-average (Mw) with PDI (Đ) by GPC/SEC.
Degree of functionalization (DOF): fraction of arms bearing biotin (ideally ~8/8). Reported by NMR integration, HPLC, or colorimetric avidin-binding assays.
Residual solvents, water content, and inorganic ash/metals (if relevant to synthesis route).
Biotin accessibility/binding capacity (stoichiometry) in streptavidin-binding tests.
UV characteristics: Biotin has weak UV absorbance above 260 nm; PEG has minimal UV background (general). Item-specific UV cutoff/absorbance: Not specified for this item.
Stabilizers: PEG-biotin generally requires no stabilizer; any stabilizer/additive used in this item is not specified.
What this means for your application: For affinity capture and multivalent assembly, prioritize lots with high DOF (≥ ~7–8/arm, literature) and narrow PDI to ensure reproducible binding density. Verify details in the CoA for this specific SKU (A163132).
Reaction and Applications
While not a small-molecule reagent, 8 Arm PEG Biotin is a versatile macromolecular affinity scaffold (general/literature) enabling multivalent biotin–(strept)avidin interactions.
Core application domains (general):
Multivalent capture and assembly: Each biotin terminus binds one avidin/streptavidin site (Kd ~10^−14–10^−15 M, literature), enabling robust, reversible-by-denaturation assemblies.
Hydrogel formation/crosslinking: Stoichiometric mixing with tetrameric streptavidin can create physical networks and soft hydrogels; gel properties depend on polymer Mn, arm length, and ratio.
Surface immobilization: Provides dense biotin presentation for biosensors, ELISA plate functionalization, SPR chips, and microarrays via streptavidin link layers.
Nanomaterials: Functionalization of nanoparticles, liposomes, or quantum dots for affinity targeting via streptavidin bridges.
Pull-down/purification: Bridging to streptavidin magnetic beads for capture of biotinylated targets or for creating multivalent competitors.
Practical tips (general):
Remove free biotin contaminants from buffers; even trace biotin competes strongly with PEG-biotin.
Use molarity of end groups (biotin sites) rather than mass of polymer when planning stoichiometry.
For hydrogel/network applications, approach the gel point by titrating streptavidin:biotin site ratios; monitor viscoelasticity by vial inversion or rheology.
Item-specific application validations from manufacturer: Not specified for this item.
Reaction Conditions
There are no classical “reaction conditions” for a polymer reagent of this type, but the following literature-general conditions support common uses with streptavidin-family proteins. These are not product specifications.
Biotin–streptavidin binding (general/literature):
pH: Broad tolerance (~4–10), commonly performed at pH 7–8 in PBS/HEPES.
Temperature: Room temperature facilitates rapid binding; cold conditions (4 °C) used to preserve sensitive biomolecules.
Ionic strength: ~100–200 mM NaCl supports protein stability and reduces nonspecific binding.
Kinetics: Association is fast; allow 15–60 min for complete binding in bulk or on surfaces depending on diffusion.
Dissociation: Very low at neutral pH; elution typically requires boiling in SDS, chaotropes (6–8 M guanidine), or competitive excess biotin for extended times (literature).
Hydrogel/network formation (general):
Mix 8-arm PEG-biotin with streptavidin near stoichiometric ratios of biotin sites to tetramer binding sites to approach the gel point; optimize by titration. Monitor gelation visually or via rheology.
Practical notes:
Calculate end-group molarity from polymer concentration and degree of functionalization (DOF). For this item, DOF and Mn are not specified; refer to CoA before planning stoichiometry.
Avoid buffers containing free biotin; filter sterilize solutions if used with proteins/cells.
Item-specific validated conditions: Not specified for this item.
Safety and Handling
Safety information specific to this item is not provided. Always consult the product SDS for authoritative guidance.
GHS classification, signal word, H-statements, pictograms: Not specified for this item; refer to SDS.
Expected hazards (general): PEGs and biotinylated PEGs are generally considered of low acute toxicity and are typically non-volatile. Dust from powders may cause mechanical irritation to eyes/respiratory tract. Avoid ingestion and inhalation of particulates.
Incompatibilities (general): Avoid strong oxidizers and strong acids/bases that can hydrolyze sensitive linkers (if ester/urethane present; exact linker for this item not specified). Thermal decomposition may produce CO/CO2 and organic vapors.
PPE (good laboratory practice): Lab coat, safety glasses, disposable nitrile gloves; use a dust mask or handle in a hood if airborne particulates may be generated.
Handling tips (general):
Open vials in a low-humidity environment to minimize moisture uptake.
For solution prep, use clean, low-biotin consumables to prevent competitive blocking in avidin/streptavidin assays.
First aid (overview; refer to SDS): Rinse eyes/skin with water upon contact; move to fresh air if inhaled; seek medical advice if symptoms persist.
Waste: Dispose according to institutional and local regulations for non-hazardous organic polymers unless SDS indicates otherwise.
Solvent Selection
Solvent choice for 8 Arm PEG Biotin is governed by PEG’s hydrophilicity and the need to preserve biotin–(strept)avidin functionality (general guidance).
Polarity/miscibility (general):
Water and aqueous buffers (PBS, TBS, HEPES) are typically preferred; good miscibility and biocompatibility.
DMSO can be used to prepare concentrated stocks, then diluted into buffer. Avoid high DMSO in biological assays to protect proteins.
Alcohols (MeOH/EtOH) and DMF may dissolve PEG-biotin but are less favored for protein-facing work.
Buffer considerations (general):
Near-neutral pH (≈6.5–8) maintains PEG integrity and biotin structure; extreme pH can hydrolyze certain linkers (if present; linkage type not specified for this item).
Include 150 mM NaCl-range ionic strength (literature) to maintain protein stability when using streptavidin/avidin.
When to choose alternatives:
For nonaqueous surface modification, consider anhydrous DMSO or DMF (then thorough solvent exchange) if the substrate is water-sensitive (general).
If high hydrophobic loading or poor solubility is encountered, gentle warming and slow buffer addition can help; otherwise consider lower-arm-count or longer-arm PEG-biotin variants (product-specific options not listed here).
Item-specific solubility limits, compatible buffers, and precipitation thresholds: Not specified for this item; refer to CoA/Spec Sheet.
Storage and Reconstitution
Storage (item-specific): Room temperature (per Product Data). Protect from moisture and contamination. If long-term storage is planned, keeping the container tightly closed with desiccant is prudent (general practice).
Shipping: Normal (per Product Data).
Reconstitution: Not specified for this item; refer to CoA/Spec Sheet. In general practice for PEG-biotins, dissolve in high-purity water or appropriate buffer and mix gently until fully solubilized. Filter sterilize if required for sensitive applications.
Freeze–thaw: Not typically applicable to dry solids. For prepared solutions, minimize freeze–thaw cycles (general). Aliquoting can help maintain integrity.
Stability: Item-specific shelf-life, water content limits, and binding capacity retention are not specified. Always review the lot-specific CoA/SDS and perform a small pilot run to confirm performance after storage.
Structure and Identity
Overview: 8 Arm PEG Biotin is a star-shaped poly(ethylene glycol) (PEG) macromolecule bearing eight PEG chains radiating from a central core, each chain terminated with a biotin moiety for high-affinity capture by avidin/streptavidin (general/literature description). Item-specific identifiers (CAS, MF, MW, SMILES, InChIKey) are not provided for this lot and are typically not defined for polymer distributions.
Chemical class: Biotin-terminated star PEG (8-arm); macromolecular conjugate (general)
Functional groups (general):
PEG ether backbone [–CH2–CH2–O–]n on each arm (neutral, hydrophilic)
Biotin end groups (ureido-imidazolidone ring fused to thiophene-like bicyclic system with valeric acid side chain) providing strong noncovalent binding to avidin-family proteins (general)
The covalent linkage between PEG and biotin can be amide/urethane/ester depending on manufacturer; exact linker chemistry for this item: Not specified
Architecture: 8-arm star (general); core type (e.g., pentaerythritol, hexaglycerol, dendritic) and arm length/Mn: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula / Molecular weight (item-specific): Not specified for this item; refer to CoA/Spec Sheet.
SMILES / InChI / InChIKey (item-specific): Not applicable for polymer distributions; Not specified.
2D structural description (general): Central multifunctional core with eight PEG chains; each terminal chain bears a biotin residue via a short linker, yielding eight avidin-binding sites per macromolecule.
Synthetic Utility
As a macromolecular building block, 8 Arm PEG Biotin provides a multivalent, hydrophilic scaffold for constructing affinity-driven architectures (general/literature):
Functional features:
Eight terminal biotin groups enable high-density anchoring to streptavidin-coated substrates or crosslinking to streptavidin to form networks.
PEG ether chains confer water solubility and spacing, reducing steric hindrance and nonspecific adsorption.
Retrosynthetic perspective:
Conceptually derived from a multifunctional core → 8 PEG arms (controlled Mn, narrow PDI) → end-group activation → biotin conjugation via amide/urethane/ester linkers (exact chemistry for this item not specified).
Typical transformations (general):
Noncovalent assembly with avidin/streptavidin/NeutrAvidin.
Covalent immobilization possible if additional functional groups remain on the core or along arms (e.g., azide/alkyne/thiol), but such groups are not specified for this item.
Use cases in synthesis and materials:
Hydrogelation and network formation for biomaterials studies.
Surface patterning via microcontact printing or inkjet deposition onto streptavidin layers.
Nanoconjugation: decorating nanoparticles with multivalent biotin for modular assembly.
Item-specific reactive groups beyond biotin termini and any residual activation: Not specified for this item; refer to CoA/Spec Sheet.
Target Specificity
Not an antibody or biochemical ligand with defined epitope mapping. Item-specific target data are not provided.
Applicable specificity (general/literature): The terminal biotin groups exhibit high specificity for avidin/streptavidin/NeutrAvidin binding sites. No other biological target specificity is implied.
Antigen name, clone, isotype, species reactivity: Not applicable to this product.
Usamos cookies para garantir o funcionamento adequado do site e, quando permitido, para melhorar a sua experiência. Você pode gerenciar suas preferências a qualquer momento nas Configurações. Saiba mais em nossa Política de Cookies.
Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?
Lembrar-me mais tarde
Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.